The Burrill Report’s Daniel Levine talks to BIO’s Alan Eisenberg regarding recent fluctuations in the financial markets and the impact on public policy. Eisenberg discusses implementation of BIO’s legislative proposals and the outlook for the industry. BIO will be hosting the BIO Investor Forum to bring together industry leaders to discuss these recent developments that could have a major influence in helping to shape the future of biotechnology.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
TagsSustainability BIO EVENT Health Care healthcare BIO Investor Forum Intellectual Property Food BIO Events GMOs global food crisis public policy BIOTECH health vaccines patent FDA Plant biotechnology USPTO patents biotechnology
- Most Popular
Latest VideoJohn Chambers, Vice Chairman, Head of Healthcare Investment Banking, ROTH Capital Partners View All >